Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Sym024 |
| Trade Name | |
| Synonyms | Sym-024|Sym 024|S095024 |
| Drug Descriptions |
Sym024 is a monoclonal antibody against CD73, which may inhibit the conversion of AMP to adenosine, reducing adenosine-mediated immunosuppression (Cancer Res (2024) 84 (6_Supplement): 3737, NCI Drug Dictionary). |
| DrugClasses | CD73 Antibody 14 |
| CAS Registry Number | NA |
| NCIT ID | C176987 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cemiplimab + Sym024 | Cemiplimab Sym024 | 0 | 1 |
| Sym021 + Sym024 | Sym021 Sym024 | 0 | 1 |
| Sym024 | Sym024 | 0 | 1 |